T. Rowe Price Associates’s Applied Genetic Technologies Corporation AGTC Stock Holding History

T. Rowe Price Associates’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-108,680	Closed	-$30K	–	3035
2022 Q3	$30K	Sell	108,680 -153,375	-59%	-$42.3K	﹤0.01%	2886
2022 Q2	$202K	Hold	262,055	–	–	﹤0.01%	2596
2022 Q1	$280K	Hold	262,055	–	–	﹤0.01%	2568
2021 Q4	$498K	Sell	262,055 -10,100	-4%	-$19.2K	﹤0.01%	2383
2021 Q3	$819K	Hold	272,155	–	–	﹤0.01%	2139
2021 Q2	$1.06M	Sell	272,155 -2,446	-0.9%	-$9.56K	﹤0.01%	2051
2021 Q1	$1.39M	Buy	274,601 +10,865	+4%	+$55.1K	﹤0.01%	1878
2020 Q4	$1.08M	Hold	263,736	–	–	﹤0.01%	1901
2020 Q3	$1.28M	Hold	263,736	–	–	﹤0.01%	1699
2020 Q2	$1.46M	Buy	263,736 +1,681	+0.6%	+$9.31K	﹤0.01%	1637
2020 Q1	$860K	Hold	262,055	–	–	﹤0.01%	1765
2019 Q4	$1.18M	Hold	262,055	–	–	﹤0.01%	1817
2019 Q3	$1.09M	Hold	262,055	–	–	﹤0.01%	1783
2019 Q2	$993K	Sell	262,055 -46,945	-15%	-$178K	﹤0.01%	1842
2019 Q1	$1.3M	Sell	309,000 -16,444	-5%	-$68.9K	﹤0.01%	1735
2018 Q4	$810K	Hold	325,444	–	–	﹤0.01%	1893
2018 Q3	$2.38M	Sell	325,444 -128,985	-28%	-$942K	﹤0.01%	1575
2018 Q2	$1.68M	Buy	454,429 +264,448	+139%	+$978K	﹤0.01%	1639
2018 Q1	$731K	Hold	189,981	–	–	﹤0.01%	1914
2017 Q4	$684K	Hold	189,981	–	–	﹤0.01%	1944
2017 Q3	$750K	Hold	189,981	–	–	﹤0.01%	1893
2017 Q2	$969K	Sell	189,981 -35	-0%	-$179	﹤0.01%	1797
2017 Q1	$1.31M	Hold	190,016	–	–	﹤0.01%	1700
2016 Q4	$1.78M	Hold	190,016	–	–	﹤0.01%	1590
2016 Q3	$1.86M	Buy	190,016 +35	+0%	+$342	﹤0.01%	1552
2016 Q2	$2.68M	Hold	189,981	–	–	﹤0.01%	1473
2016 Q1	$2.66M	Hold	189,981	–	–	﹤0.01%	1476
2015 Q4	$3.88M	Hold	189,981	–	–	﹤0.01%	1455
2015 Q3	$2.5M	Hold	189,981	–	–	﹤0.01%	1522
2015 Q2	$2.91M	Sell	189,981 -18,254	-9%	-$280K	﹤0.01%	1536
2015 Q1	$4.16M	Sell	208,235 -155,622	-43%	-$3.11M	﹤0.01%	1495
2014 Q4	$7.65M	Buy	+363,857	New	+$7.65M	﹤0.01%	1391